The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.
The DCP Cancer Biomarkers Research Group administers this program.
Visit the EDRN website
The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.
PCDC EDRN-APaCC Joint (Virtual) Meeting Registration Now Open
The National Cancer Institute’s Pancreatic Cancer Detection Consortium (PCDC) and Early Detection Research Network – Alliance of Pancreatic Cancer Consortia for Early Detection (EDRN-APaCC) Joint Meeting (Virtual) will take place on December 13, 2021 from 10:30a.m.-5:30p.m. ET. Registration is now open.
Early Detection Research Network Marks 20 Years
This month, the Early Detection Research Network (EDRN) marks its 20th anniversary. The National Cancer Institute (NCI) launched the network in 2000 with the goal of identifying and harnessing biomarkers as a way of detecting cancer at earlier stages. Today, the network comprises more than 300 researchers at cancer centers around the United States.